2026 Q3 Portfolio Activity
In 2026 Q3, Knott David M Jr maintained a portfolio of 92 distinct positions. The most significant new addition was Oruka Therapeutics, Inc., now representing 0.50% of the total fund value. They heavily accumulated shares in LPL Financial Holdings Inc., increasing the position by 338.0%. Conversely, Knott David M Jr completely exited their position in Catalyst Pharmaceuticals, Inc..
Position History
hover any row below to update
Loading…
Total Positions
92
Quarter
2026 Q3
Top Holding
GOOG (17.0%)
Top 10 Concentration
66.7%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-50 of 92
Knott David M Jr Full Holdings List — 2026 Q3
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
GOOG
Alphabet Inc-Cl...
|
Communication Services | 17.04% | 17.07% |
#1
Prev: #1
|
7.0 |
—
|
no change | no change |
P
S
|
91,420 | $31,150,451 | 2021 Q4 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
APO
Apollo Global M...
|
Financial Services | 14.28% | 14.07% |
#2
Prev: #2
|
6.5 |
—
|
no change | no change |
P
S
|
225,000 | $26,113,500 | 2021 Q4 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
IOVA
Iovance Biother...
|
Healthcare | 9.44% | 3.52% |
#3
5
Prev: #8
|
4.8 |
—
|
-435,000 | -27.2% |
P
S
|
1,165,000 | $17,265,300 | 2021 Q4 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
XERS
Xeris Biopharma...
|
Healthcare | 5.24% | 4.44% |
#4
Prev: #4
|
3.1 |
—
|
-57,100 | -5.4% |
P
S
|
1,002,900 | $9,587,724 | 2023 Q4 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
SNDX
Syndax Pharmace...
|
Healthcare | 4.40% | 5.05% |
#5
2
Prev: #3
|
2.8 |
—
|
-8,951 | -2.0% |
P
S
|
428,294 | $8,051,927 | 2024 Q1 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
TVTX
Travere Therape...
|
Healthcare | 4.19% | 4.42% |
#6
1
Prev: #5
|
2.2 |
—
|
-17,315 | -11.8% |
P
S
|
129,967 | $7,652,457 | 2023 Q3 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
BBIO
Bridgebio Pharm...
|
Healthcare | 3.60% | 3.66% |
#7
Prev: #7
|
3.4 |
—
|
7,150 | 7.7% |
P
S
|
100,000 | $6,580,000 | 2022 Q1 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
JPM
JPMorgan Chase ...
|
Financial Services | 3.15% | 3.13% |
#8
2
Prev: #10
|
1.8 |
—
|
-689 | -3.8% |
P
S
|
17,409 | $5,759,419 | 2021 Q4 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
N/A
LPL Financial H...
|
|
Unknown | 2.76% | 2.46% |
#9
3
Prev: #12
|
2.1 |
—
|
no change | no change |
P
S
|
16,500 | $5,045,700 | — | 13F Filing | 2026-09-30 | 2026-11-12 | ||
|
JAAA
Janus Henderson...
|
ETF | 2.58% | 2.50% |
#10
1
Prev: #11
|
2.0 |
—
|
no change | no change |
P
S
|
93,528 | $4,720,358 | 2023 Q3 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
ALKS
Alkermes PLC
|
Healthcare | 2.54% | 3.37% |
#11
2
Prev: #9
|
1.5 |
—
|
-7,300 | -6.0% |
P
S
|
114,459 | $4,637,879 | 2023 Q2 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
PTGX
Protagonist The...
|
Healthcare | 2.52% | 4.08% |
#12
6
Prev: #6
|
1.0 |
—
|
-30,277 | -48.1% |
P
S
|
32,723 | $4,610,343 | 2023 Q3 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
CYBN
Cybin Inc
|
Unknown | 2.49% | 1.29% |
#13
7
Prev: #20
|
2.0 |
—
|
no change | no change |
P
S
|
370,000 | $4,547,300 | 2024 Q4 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
COGT
Cogent Bioscien...
|
Healthcare | 2.38% | 2.27% |
#14
1
Prev: #13
|
3.5 |
—
|
25,000 | 22.5% |
P
S
|
136,081 | $4,357,314 | 2025 Q1 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
VRDN
Viridian Therap...
|
Healthcare | 2.15% | 1.76% |
#15
2
Prev: #17
|
2.9 |
—
|
10,000 | 5.5% |
P
S
|
191,000 | $3,932,690 | 2024 Q4 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
TGTX
TG Therapeutics...
|
Healthcare | 1.83% | 1.94% |
#16
2
Prev: #14
|
1.2 |
—
|
-7,000 | -10.5% |
P
S
|
59,839 | $3,337,819 | 2021 Q4 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
RCUS
Arcus Bioscienc...
|
Healthcare | 1.42% | 1.32% |
#17
2
Prev: #19
|
3.1 |
—
|
19,000 | 23.4% |
P
S
|
100,241 | $2,589,225 | 2025 Q1 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
MDGL
Madrigal Pharma...
|
Healthcare | 0.99% | 0.85% |
#18
6
Prev: #24
|
2.9 |
—
|
600 | 20.0% |
P
S
|
3,600 | $1,814,256 | 2022 Q3 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
RLMD
Relmada Therape...
|
Healthcare | 0.99% | 1.65% |
#19
1
Prev: #18
|
2.4 |
—
|
29,000 | 6.4% |
P
S
|
480,000 | $1,809,600 | 2021 Q4 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
XBI
SPDR S&P Biotec...
|
ETF | 0.95% | 1.25% |
#20
1
Prev: #21
|
0.4 |
—
|
-4,000 | -26.7% |
P
S
|
11,000 | $1,734,480 | 2021 Q4 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
AB
AllianceBernste...
|
Financial Services | 0.92% | 0.89% |
#21
2
Prev: #23
|
1.4 |
—
|
no change | no change |
P
S
|
48,000 | $1,674,240 | 2021 Q4 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
AGIO
Agios Pharmaceu...
|
Healthcare | 0.89% | 1.86% |
#22
6
Prev: #16
|
0.4 |
—
|
-46,000 | -48.4% |
P
S
|
49,058 | $1,631,178 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
OBIO
Orchestra Biome...
|
Healthcare | 0.86% | 0.58% |
#23
10
Prev: #33
|
1.3 |
—
|
no change | no change |
P
S
|
253,651 | $1,577,709 | 2025 Q2 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
CGEM
Cullinan Therap...
|
Healthcare | 0.80% | 0.67% |
#24
6
Prev: #30
|
2.8 |
—
|
26,187 | 37.9% |
P
S
|
95,369 | $1,463,914 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
CDNA
CareDx, Inc.
|
Healthcare | 0.79% | 0.21% |
#25
25
Prev: #50
|
3.3 |
—
|
8,535 | 62.6% |
P
S
|
22,165 | $1,440,725 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
ELVN
Enliven Therape...
|
Healthcare | 0.72% | 0.17% |
#26
26
Prev: #52
|
3.3 |
—
|
22,721 | 367.5% |
P
S
|
28,904 | $1,324,959 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
SPRB
Spruce Bioscien...
|
Healthcare | 0.69% | 0.57% |
#27
7
Prev: #34
|
2.8 |
—
|
6,085 | 30.4% |
P
S
|
26,085 | $1,267,209 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
CLOZ
Eldgridge BBB-B
|
Unknown | 0.69% | 0.67% |
#28
1
Prev: #29
|
1.3 |
—
|
no change | no change |
P
S
|
47,807 | $1,257,324 | 2023 Q3 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
DCGO
DocGo, Inc.
|
Healthcare | 0.58% | 0.73% |
#29
3
Prev: #26
|
1.2 |
—
|
no change | no change |
P
S
|
2,670,850 | $1,067,806 | 2021 Q4 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
PFE
Pfizer Inc.
|
Healthcare | 0.50% | 0.41% |
#30
8
Prev: #38
|
1.2 |
—
|
no change | no change |
P
S
|
32,337 | $922,251 | 2021 Q4 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
ORKA
Oruka Therapeut...
|
Healthcare | 0.50% | — |
#31
Prev: #—
|
3.7 |
—
|
11,000 | — |
NEW
|
11,000 | $916,190 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
COLL
Collegium Pharm...
|
Healthcare | 0.47% | — |
#32
Prev: #—
|
3.7 |
—
|
39,000 | — |
NEW
|
39,000 | $850,980 | 2024 Q4 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
DYN
Dyne Therapeuti...
|
Healthcare | 0.46% | — |
#33
Prev: #—
|
3.7 |
—
|
52,000 | — |
NEW
|
52,000 | $837,720 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
AAPL
Apple Inc.
|
Technology | 0.45% | 0.38% |
#34
5
Prev: #39
|
1.2 |
—
|
no change | no change |
P
S
|
2,494 | $830,552 | 2021 Q4 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
MSFT
Microsoft Corpo...
|
Technology | 0.45% | 0.32% |
#35
8
Prev: #43
|
1.2 |
—
|
no change | no change |
P
S
|
1,600 | $820,640 | 2021 Q4 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
JNJ
Johnson & Johns...
|
Healthcare | 0.42% | 0.66% |
#36
5
Prev: #31
|
0.2 |
—
|
-2,000 | -40.6% |
P
S
|
2,922 | $773,570 | 2021 Q4 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
RZLT
Rezolute, Inc.
|
Healthcare | 0.36% | 1.02% |
#37
15
Prev: #22
|
0.1 |
—
|
-210,362 | -56.9% |
P
S
|
159,638 | $660,901 | 2025 Q3 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
CNQ
Canadian Natura...
|
Energy | 0.36% | 0.35% |
#38
2
Prev: #40
|
0.6 |
—
|
-2,882 | -17.2% |
P
S
|
13,918 | $655,120 | 2021 Q4 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
LBRX
LB Pharmaceutic...
|
Healthcare | 0.36% | 0.22% |
#39
10
Prev: #49
|
2.6 |
—
|
4,100 | 31.6% |
P
S
|
17,065 | $654,955 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
IBB
iShares Biotech...
|
ETF | 0.29% | 0.55% |
#40
4
Prev: #36
|
0.1 |
—
|
-3,000 | -54.5% |
P
S
|
2,500 | $526,325 | 2025 Q2 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
SLDB
Solid Bioscienc...
|
Healthcare | 0.28% | 0.30% |
#41
5
Prev: #46
|
2.6 |
—
|
14,921 | 26.5% |
P
S
|
71,129 | $514,263 | 2025 Q1 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
DD
DuPont de Nemou...
|
Basic Materials | 0.27% | — |
#42
Prev: #—
|
3.6 |
—
|
3,767 | — |
NEW
|
3,767 | $489,296 | 2021 Q4 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
IBM
International B...
|
Technology | 0.26% | 0.32% |
#43
1
Prev: #42
|
1.1 |
—
|
no change | no change |
P
S
|
2,142 | $471,090 | 2023 Q1 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
N/A
Connect Biophar...
|
|
Unknown | 0.25% | 0.56% |
#44
9
Prev: #35
|
0.6 |
—
|
-24,996 | -5.6% |
P
S
|
419,866 | $461,853 | — | 13F Filing | 2026-09-30 | 2026-11-12 | ||
|
BIIB
Biogen Inc.
|
Healthcare | 0.25% | 0.46% |
#45
8
Prev: #37
|
0.1 |
—
|
-2,000 | -50.0% |
P
S
|
2,000 | $451,760 | 2025 Q3 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
EWTX
Edgewise Therap...
|
Healthcare | 0.23% | — |
#46
Prev: #—
|
3.6 |
—
|
10,502 | — |
NEW
|
10,502 | $426,381 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
PTHS
Pelthos Therape...
|
Healthcare | 0.20% | 0.33% |
#47
6
Prev: #41
|
0.1 |
—
|
-4,429 | -20.1% |
P
S
|
17,644 | $370,700 | 2025 Q3 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
NVDA
Nvidia Corp
|
Technology | 0.16% | 0.14% |
#48
8
Prev: #56
|
1.1 |
—
|
no change | no change |
P
S
|
1,280 | $292,326 | 2022 Q2 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
RHP
Ryman Hospitali...
|
Real Estate | 0.16% | 0.16% |
#49
4
Prev: #53
|
1.1 |
—
|
no change | no change |
P
S
|
2,400 | $286,872 | 2021 Q4 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
INSM
Insmed Incorpor...
|
Healthcare | 0.14% | 0.24% |
#50
2
Prev: #48
|
0.1 |
—
|
-2,000 | -47.0% |
P
S
|
2,253 | $257,157 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-12 |
Showing 1-50 of 92 holdings